The prevalence of peripheral neuropathy among the patients with diabetes in Pakistan: a systematic review and meta-analysis

Author:

Akhtar Sohail,Hassan Fazal,Saqlain Seda Rakhshanda,Ali Aqsa,Hussain Sardar

Abstract

AbstractThe most frequent complication of diabetes is peripheral neuropathy. The estimated prevalence of peripheral neuropathy in people with diabetes varies substantially between published studies in Pakistan. We conducted this meta-analysis to summarize the prevalence of peripheral neuropathy in people with diabetes. Different electronic databases were systematically searched using keywords and MeSH terms. Random-effects meta-analysis was conducted to pool the prevalence of peripheral neuropathy in people with diabetes in Pakistan. Heterogeneity was investigated by random-effects meta-regression and stratification. Two independent authors reviewed studies, extracted data, and conducted the risk of bias analysis. Nineteen studies with a total of 8487 diabetic patients were included. The overall pooled prevalence of diabetic peripheral neuropathy was 43.16% (95% CI 32.93–53.69%), with significant heterogeneity between estimates. The prevalence of peripheral neuropathy among those newly diagnosed with diabetes was 26.52% (95% CI 14.97–39.96%, n = 5). According to the subgroup meta-analysis, the pooled prevalence of diabetic peripheral neuropathy was highest in Khyber Pakhtunkhwa (55.29%; 95% CI 23.91–84.50%), followed by Sindh (40.04%; 95% CI 24.00–57.25%), and the lowest was found in Punjab (34.90%; 95% CI 15.05–57.95%). A significant association was found between the pooled prevalence estimate and the duration of diabetes. The results of this meta-analysis indicate a relatively high prevalence of peripheral neuropathy in people with diabetes in Pakistan. The study protocol has been registered in the PROSPERO, with the registration number CRD42022371617.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference61 articles.

1. Diabetes World Health Organization. https://www.who.int/news-room/fact-sheets/detail/diabetes (Accessed Jan 2, 2023).

2. Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 1(183), 109119 (2022).

3. https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/heart-disease-stroke

4. Diabetes, Heart Disease, and Stroke—NIDDK National Institute of Diabetes and Digestive and Kidney Diseases. U.S. Department of Health and Human Services. https://www.niddk.nih.gov/health-information/diabetes/overview/preventingproblems/heart-disease-stroke (Accessed Jan 2, 2023).

5. Jwad, S. M. & Al-Fatlawi, H. Y. Types of diabetes and their effect on the immune system. J Adv Pharm Pract 4, 21–30 (2022).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3